Get the Stockscreener App
0.4022
1.75%
0.0069
After Hours:
.40
-0.0022
-0.55%
IGC Pharma Inc stock is traded at $0.4022, with a volume of 2.95M.
It is up +1.75% in the last 24 hours and down -0.86% over the past month.
India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.
See More
Previous Close:
$0.3953
Open:
$0.4025
24h Volume:
2.95M
Relative Volume:
3.13
Market Cap:
$36.99M
Revenue:
$1.22M
Net Income/Loss:
$-14.15M
P/E Ratio:
-1.5469
EPS:
-0.26
Net Cash Flow:
$-6.55M
1W Performance:
-4.08%
1M Performance:
-0.86%
6M Performance:
+33.27%
1Y Performance:
+4.39%
1-Day Range:
$0.38
$0.4508
1-Week Range:
$0.38
$0.4508
52-Week Range:
$0.2525
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
Name
IGC Pharma Inc
Sector
Industry
Phone
301-983-0998
Address
4336 Montgomery Avenue, Bethesda, MD
Compare IGC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.4022 | 36.35M | 1.22M | -14.15M | -6.55M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
IGC Pharma Inc Stock (IGC) Latest News
IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline - GuruFocus
Intraday pattern recognizer results for IGC Pharma Inc.Quarterly Profit Summary & Safe Capital Growth Stock Tips - newser.com
Visual analytics tools that track IGC Pharma Inc. performanceTake Profit & Intraday High Probability Setup Alerts - newser.com
IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline (2025-11-03) - Seeking Alpha
Has IGC Pharma Inc. formed a bullish divergencePortfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com
Is IGC Pharma Inc. stock worth holding before Fed meeting2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
How sentiment analysis helps forecast IGC Pharma Inc.Trade Risk Report & Expert Approved Momentum Trade Ideas - newser.com
Why IGC Pharma Inc. stock stays undervaluedWall Street Watch & Risk Managed Trade Strategies - newser.com
Is IGC Pharma Inc. forming a bottoming baseWatch List & Technical Buy Zone Confirmation - newser.com
Why IGC Pharma Inc. stock attracts global investorsQuarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Can you recover from losses in IGC Pharma Inc.Gap Up & Free Technical Confirmation Trade Alerts - newser.com
How supply shortages influence IGC Pharma Inc. (IGS1) stockJuly 2025 Analyst Calls & Expert Approved Momentum Ideas - newser.com
Can IGC Pharma Inc. stock sustain revenue growthJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com
How IGC Pharma Inc. (IGS1) stock moves in volatile trading sessionsInsider Buying & Long Hold Capital Preservation Plans - newser.com
Is IGC Pharma Inc. stock a safe buy before earningsJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com
Price action breakdown for IGC Pharma Inc.July 2025 Movers & Daily Oversold Bounce Ideas - newser.com
Is IGC Pharma Inc. a candidate for recovery playMarket Movement Recap & Step-by-Step Trade Execution Guides - newser.com
Will IGC Pharma Inc. stock gain from government policiesEarnings Performance Report & Free Real-Time Market Sentiment Alerts - newser.com
Exit strategy if you’re trapped in IGC Pharma Inc.Market Performance Summary & Low Drawdown Trading Techniques - newser.com
Can IGC Pharma Inc. stock sustain breakout momentumWeekly Stock Summary & Community Consensus Stock Picks - newser.com
Will earnings trigger a reversal in IGC Pharma Inc.Market Sentiment Review & Real-Time Stock Price Movement Reports - newser.com
IGC Pharma Inc Stock (IGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):